China Biotech Services Holdings Limited

HK$0.35As of Sun 8 Nov 2026, 12:00 UTC
HKEX:8037Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 1.30%
Div yield —
ROE (14.96%)
Diagnostics & Research
Beta (5Y) (0.36)
PE TTM —
TSR TTM (53.90%)
Mkt cap HK$346.4M
ROIC (15.34%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.414
16.69%
(43.78%)
Hold 6|9|2|6|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
0.01
0.01
2.19%
16.47%
30.97%
26.78%
Revenue$M
26.12
26.57
26.65
28.09
4.16%
6.41%
4.25%
6.50%
Peers (US$44.18M)
Cap (US$)
PE
35.84M
4.009x
Capital
TTM
5Y
10Y
Leveragex
1.816
(0.039)
(0.031)
EBIT/Intx
0.202
0.340
0.352
Own earn%
1.27
(95.11)
(99.03)
Sh yield%
36.82
26.22
27.79
Owners
Insiders/Inst%
12.05
89.72
Short interest%
2.62
SBC / revenue%
2.94
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
26–31
$1 testx
1.9
Incr. ROIC%
8